Sutro Biopharma (FRA:S09) 3-Year EBITDA Growth Rate : -9.80% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Sutro Biopharma 3-Year EBITDA Growth Rate?

Sutro Biopharma's EBITDA per Share for the three months ended in Mar. 2024 was €-0.70.

During the past 3 years, the average EBITDA Per Share Growth Rate was -9.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 19.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sutro Biopharma was 28.60% per year. The lowest was -9.80% per year. And the median was 13.25% per year.

Competitive Comparison of Sutro Biopharma's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Sutro Biopharma's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sutro Biopharma's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sutro Biopharma's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Sutro Biopharma's 3-Year EBITDA Growth Rate falls into.

Sutro Biopharma 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Sutro Biopharma (FRA:S09) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Sutro Biopharma 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Sutro Biopharma's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sutro Biopharma (FRA:S09) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sutro Biopharma Inc (FRA:S09) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

STRO:USA

Address

111 Oyster Point Boulevard, South San Francisco, CA, USA, 94080

Website

https://www.sutrobio.com

Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

Sutro Biopharma (FRA:S09) Headlines

No Headlines